↓ Skip to main content

Ibrutinib and Indolent B-Cell Lymphomas

Overview of attention for article published in Clinical Lymphoma, Myeloma & Leukemia, November 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
1 X user
patent
5 patents

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Ibrutinib and Indolent B-Cell Lymphomas
Published in
Clinical Lymphoma, Myeloma & Leukemia, November 2013
DOI 10.1016/j.clml.2013.11.005
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 2%
Unknown 46 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 10 21%
Researcher 6 13%
Other 5 11%
Student > Bachelor 5 11%
Student > Ph. D. Student 5 11%
Other 8 17%
Unknown 8 17%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 17 36%
Agricultural and Biological Sciences 8 17%
Biochemistry, Genetics and Molecular Biology 6 13%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Chemical Engineering 1 2%
Other 3 6%
Unknown 9 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2025.
All research outputs
#11,484,016
of 34,447,360 outputs
Outputs from Clinical Lymphoma, Myeloma & Leukemia
#887
of 2,697 outputs
Outputs of similar age
#88,411
of 259,129 outputs
Outputs of similar age from Clinical Lymphoma, Myeloma & Leukemia
#9
of 31 outputs
Altmetric has tracked 34,447,360 research outputs across all sources so far. This one has received more attention than most of these and is in the 65th percentile.
So far Altmetric has tracked 2,697 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,129 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.